This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Universitéde Liége, University of Florida Research Foundation Inc.. Active years: 2019.
Company Filing History:
1 out of 86 
1 out of 3,046 
Years Active: 2019
Title: Samuel Jourdan: Innovator in Thaxtomin Production
Introduction
Samuel Jourdan is a notable inventor based in Bastogne, Belgium. He has made significant contributions to the field of biotechnology, particularly in the production of thaxtomin, a compound with various applications in agriculture and medicine. His innovative work has led to the development of genetically modified bacteria capable of increased thaxtomin production.
Latest Patents
Samuel Jourdan holds a patent for "Methods for thaxtomin production and modified streptomyces with increased thaxtomin production." This patent outlines methods involving genetically modified bacteria that exhibit enhanced thaxtomin production. The methods include suppressing the activity of specific proteins and enzymes, which are crucial for optimizing thaxtomin yield.
Career Highlights
Throughout his career, Samuel Jourdan has worked with esteemed institutions such as the University of Florida Research Foundation Inc and Université de Liège. His research has focused on genetic modifications that improve the efficiency of thaxtomin production, contributing to advancements in agricultural biotechnology.
Collaborations
Samuel has collaborated with notable colleagues, including Sebastien Rigali and Isolde Maria Francis. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Samuel Jourdan's work in thaxtomin production exemplifies the impact of innovative research in biotechnology. His contributions continue to influence the development of genetically modified organisms for agricultural applications.